Evidence map›Paper›PMID 40200041›Full record

ReviewNature protocols2025

Sequential orthogonal assays for longitudinal and endpoint characterization of three-dimensional spheroids.

Eva Blondeel, Sam Ernst, Felix De Vuyst, Ákos Diósdi, Cláudio Pinheiro, Diogo Estêvão, Pekka Rappu, Robin Boiy, Sándor Dedeyne, Ligia Craciun and 16 more

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Eva BlondeelLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID 0000-0002-2570-2207
Sam ErnstLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID 0000-0003-2210-8007
Felix De VuystLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Ákos DiósdiSynthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary.
Cláudio PinheiroLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID 0000-0003-1834-199X
Diogo Estêvãoi3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.ORCID 0000-0001-6457-2356
Pekka RappuDepartment of Life Technologies and InFLAMES Flagship, University of Turku, Turku, Finland.ORCID 0000-0002-5068-2842
Robin BoiyLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Sándor DedeyneLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Ligia CraciunCerbaPath, Division CMP, Brussels, Belgium.
Vera GoossensVIB Screening Core and Ghent University Expertise Centre for Bioassay Development and Screening, Ghent University, Ghent, Belgium.
Jonas DehairsLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
Tânia Cruzi3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Dominique AudenaertVIB Screening Core and Ghent University Expertise Centre for Bioassay Development and Screening, Ghent University, Ghent, Belgium.
Wim CeelenCancer Research Institute Ghent, Ghent, Belgium.
Michael LinnebacherClinic of General Surgery, Molecular Oncology and Immunotherapy, University of Rostock, Rostock, Germany.ORCID 0000-0001-8054-1402
Tom BoterbergCancer Research Institute Ghent, Ghent, Belgium.ORCID 0000-0001-8680-8737
Jo VandesompeleCancer Research Institute Ghent, Ghent, Belgium.ORCID 0000-0001-6274-0184
Pieter MestdaghCancer Research Institute Ghent, Ghent, Belgium.
Johan SwinnenLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
Jyrki HeinoDepartment of Life Technologies and InFLAMES Flagship, University of Turku, Turku, Finland.
Peter HorvathSynthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary.ORCID 0000-0002-4492-1798
Maria José Oliveirai3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
An HendrixLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID 0000-0002-1883-8309
Pieter DemetterCerbaPath, Division CMP, Brussels, Belgium.
Olivier De WeverLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium. Olivier.Dewever@UGent.be.ORCID 0000-0002-5453-760X

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1198123NMinistry of Education and Science | Fundação para a Ciência e a Tecnologia (Portuguese Science and Technology Foundation) EXPL/BIA-CEL/1225/2021Ministry of Education and Science | Fundação para a Ciência e a Tecnologia (Portuguese Science and Technology Foundation) PTDC/ MED-ONC/4165/2021Ministry of Education and Science | Fundação para a Ciência e a Tecnologia (Portuguese Science and Technology Foundation) UI/BD/151551/2021Sigrid Juséliuksen Säätiö (Sigrid Jusélius Foundation) 362311Suomen Akatemia | Terveyden Tutkimuksen Toimikunta (Research Council for Health) 329743
6 · The paper itself

Abstract

Spheroids are reaggregated multicellular three-dimensional structures generated from cells or cell cultures of healthy as well as pathological tissue. Basic and translational spheroid application across academia and industry have led to the development of multiple setups and analysis methods, which mostly lack the modularity to maximally phenotype spheroids. Here we present the self-assembly of single-cell suspensions into spheroids by the liquid overlay method, followed by a modular framework for a multifaceted phenotyping of spheroids. Cell seeding, supernatant handling and compound administration are elaborated by both manual and automated procedures. The phenotyping modules contain a suite of orthogonal assays to analyze spheroids longitudinally and/or at an endpoint. Longitudinal analyses include morphometry with or without spheroid or cell state specific information and supernatant evaluation (nutrient consumption and metabolite/cytokine production). Spheroids can also be used as a starting point to monitor single and collective cell migration and invasion. At an endpoint, spheroids are lysed, fixed or dissociated into single cells. Endpoint analyses allow the investigation of molecular content, single-cell composition and state and architecture with spatial cell and subcellular specific information. Each module addresses time requirements and quality control indicators to support reproducibility. The presented complementary techniques can be readily adopted by researchers experienced in cell culture and basic molecular biology. We anticipate that this modular protocol will advance the application of three-dimensional biology by providing scalable and complementary methods.

Indexed as

Cell Culture TechniquesCell Culture Techniques, Three DimensionalSpheroids, CellularHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.